A Study of SGN-ALPV in Advanced Solid Tumors

A Study of SGN-ALPV in Advanced Solid Tumors
Conditions:   Ovarian Neoplasms;   Endometrial Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Stomach Neoplasms;   Uterine Cervical Neoplasms;   Testicular Neoplasms
Intervention:   Drug: SGN-ALPV
Sponsor:   Seagen Inc.

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 11, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine